HB 405 amends Louisiana law to establish licensure requirements for acupuncturists. It requires practitioners to hold active certification from the National Certification Commission for Acupuncture and Oriental Medicine (NCCAOM) and pass its certification exam, including the Biomedicine portion. The bill updates the legal reference to the certifying organization's name to match its current official title. This directly affects individuals seeking to practice acupuncture in Louisiana by setting standardized certification criteria. The bill is currently in committee referral and has not yet been enacted.
HB 779 allows Louisiana doctors, nurses, and physician assistants to prescribe antibiotics to a patient’s sexual partner for certain sexually transmitted infections (STIs) like chlamydia, gonorrhea, or trichomoniasis - without requiring a direct exam or doctor-patient relationship with the partner. It requires providers to give the patient a written document to share with their partner, detailing the prescribed treatment. The bill also grants legal protection to healthcare providers who follow these guidelines in good faith. This policy directly affects patients diagnosed with eligible STIs and their partners, aiming to improve treatment access while reducing infection spread.
This resolution directs the Louisiana Department of Health to partner with the University of Louisiana at Lafayette and other experts to study how to prevent and reduce diabetes-related amputations in the state. The study will examine current amputation rates, associated healthcare costs, and evidence-based strategies such as early detection, improved patient education, and expanded access to limb-saving treatments. A specialized workgroup of medical professionals and community members will guide the research, with findings and policy recommendations due to the legislature by December 1, 2026.
This bill asks state agencies and law enforcement groups to report on how they are using opioid settlement funds for treatment and prevention programs in correctional facilities. It also requests that the Opioid Abatement Task Force and the Attorney General provide clearer guidance on which expenses are allowed under these funds. The measure aims to address concerns raised in a recent audit that many local areas have not spent their allocated money due to confusion about rules and a lack of available programs. By gathering this information, the state hopes to ensure that the millions of dollars received from opioid lawsuits are used effectively to help incarcerated individuals with substance use disorders.
This bill is a formal request from the Louisiana legislature to the U.S. Congress and federal health agencies to speed up research and clinical trials for Acute Myeloid Leukemia. It does not create new laws or change funding directly but instead asks federal officials to prioritize efforts to develop better treatments for this aggressive blood cancer. The resolution also names these proposed research efforts the "Jonas A. Feeley Act" to honor a recent victim of the disease. Ultimately, the measure serves as a symbolic gesture to advocate for increased federal attention on improving survival rates for patients with this condition.
This bill requests the Louisiana Department of Health and Department of Education to create a comprehensive report on the current state of autism support services in Louisiana. The report will examine diagnostic practices, service availability, and access barriers across healthcare and education sectors, involving collaboration with the Louisiana Chapter of the American Academy of Pediatrics. It will assess diagnostic tools, provider training, wait times, and compare Louisiana's services to other states to identify gaps and areas for improvement. The final report must be submitted to the legislature by January 1, 2027, to inform future policy decisions regarding autism support.
This bill establishes a Task Force on School Nurse Orientation in Louisiana to create a training program for new registered nurses entering public schools. The task force will review existing orientation programs, identify essential skills for school nurses, and develop recommendations for standardized training and mentorship opportunities. It will consist of nine representatives from various organizations including nursing associations, education agencies, and health departments, and must begin its work by August 1, 2026. The group will submit its recommendations to the legislature and will dissolve once its work is complete or by February 12, 2027.
HB 77 requires the Lincoln Parish Clerk of Court to pay 100% of group insurance premiums (including life, health, dental, and medical expense coverage) for qualifying retirees. It directly affects former Lincoln Parish Clerk of Court employees who retire with at least 20 years of full-time service, are age 55 or older, and begin receiving retirement benefits immediately upon retirement. The bill specifically covers standard group insurance plans but excludes supplemental insurance options. This provision is limited to Lincoln Parish and applies only to retirees meeting these exact service and age requirements.
This bill updates Louisiana law to clarify the roles of nurses in administering medications within public health clinics. It allows registered nurses, nurse practitioners, and advanced practice registered nurses to insert subcutaneous medication implants and distribute certain medications for treating sexually transmitted diseases or preventing pregnancy under physician-approved protocols. Additionally, the bill permits these licensed nurses to administer reconstituted medications for intravenous therapy when used according to the medication's labeling, while explicitly stating that this process does not constitute compounding. The changes apply specifically to nurses employed by municipal, parochial, or state-operated public health clinics and require adherence to established procedures and protocols.
SB 30 prohibits Louisiana state agencies and licensing boards from banning telehealth services for evaluating, diagnosing, or treating obesity and related metabolic conditions. It directly affects licensed healthcare providers who use telehealth to deliver these services. The bill requires that providers may prescribe FDA-approved or compounded noncontrolled medications via telehealth while operating within their license scope and standard of care. This policy change removes regulatory barriers to telehealth for these specific conditions, without altering existing licensure requirements.